BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BioPharma Clinical Trials

FDA Pre-Submission for Saliva-Based Glucose Test to Replace Invasive Finger-Prick

The purpose of this Pre-Submission is to confirm with the FDA the clinical trial design, including trial objectives. This interaction will allow the FDA to...

October 20, 2021 | News

MYND to Participate in a Monash University (Australia) Proposal for $3 Million Clinical Trial

MYND Diagnostics Inc., a wholly-owned subsidiary of MYND Life Sciences (CSE: MYND) (OTC: MYNDF) is pleased to announce that the Company's pr...

October 18, 2021 | News

Biocytogen announces collaboration with Envigo

Biocytogen announces a collaboration with Envigo, a global organization that offers the widest range of research models and related services. The two compa...

September 29, 2021 | News

ACROMEC's associated Life Science Incubator launches Co-working Labspace

ACROMEC Limited a specialist engineering services provider, announced that subsidiary ACROMEC Engineers Pte Ltd (ACROMEC Engineers) through joint-venture a...

September 24, 2021 | News

Singapore Approved New Therapy to Treat Advanced Small Cell Lung Cancer

ZEPZELCA® (lurbinectedin) is the first new therapy approved in Singapore to treat 2L metastatic small cell lung cancer (SCLC) in 20...

September 23, 2021 | News

Bionomics Prepares BNC210 for Start of Phase 2 Acute Treatment of Social Anxiety Disorder Trial

Rapid oral absorption of BNC210 novel tablet formulation potentially well-suited for acute treatment of anxiety in patients with Social Anxiety D...

September 21, 2021 | News

Jemincare declared Ph I trial of its anti-SARS-CoV-2 neutralizing antibody

The clinical trial of JMB2002 was stated in January 2021. A single-center, randomized, double-blind, placebo-controlled, single-dose escalation phas...

September 14, 2021 | News

Novavax Launches Ph 1 & 2 ,Clinical Trial of Combined COVID-19 and Seasonal Influenza Vaccine

First participants enrolled in Phase 1 clinical trial of NanoFlu combination vaccineTM/NVX–CoV2373 with Matrix-M adjuvantTM Novavax, Inc. (Nasdaq:&n...

September 11, 2021 | News

Illumina Partners with Merck to advance cancer diagnostics and precision medicine.

Illumina, Inc. (NASDAQ: ILMN) and Merck (known as MSD outside the United States and Canada) today announced a partnership to develop an...

September 08, 2021 | News

Odyssey Group Approved to Start Human Trial to Treat Concussion

The Company’s Clinical Trial Protocol was approved by the Alfred Ethics Committee and allows for the immediate start of the human trial. “We a...

September 08, 2021 | News

Stem Cells for Everyone: I Peace expands its clinical-grade

I Peace, Inc. (CEO: Koji Tanabe, https://ipeace.com/), a Palo Alto-based biotech startup focusing on Nobel Prize-winning technology of ...

September 08, 2021 | News

NuProbe Enables Rapid Ultrasensitive Mutation Detection

he method, termed oncogene concatenated enriched amplicon nanopore sequencing (OCEANS), enables rapid, accurate, and affordable detection of somatic mutati...

September 07, 2021 | News

CSL Behring Underscores its Commitment to Respiratory Patients with Strong Focus on Research

Focusing on what we have learnt about the impact of global Covid-19 pandemic on pulmonary disease research, it will also explore the latest updates in the ...

September 06, 2021 | News

Pfizer Starts PhIII Clinical Trial in Adults for Its Vaccine Against Respiratory Syncytial Virus (RSV)

Pfizer Inc. (NYSE:PFE) today announced the initiation of RENOIR (RSV vaccine Efficacy study iNOlder adults Immunized against RSV disease), a...

September 02, 2021 | News

Stay Connected